Home › Calculator › CGEM Dividend Calculator 2026
CGEM Dividend Calculator 2026
No dividendHealthcareCullinan Therapeutics, Inc. · NASDAQ
Price: $14.37 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
CGEM is not a dividend-focused stock
CGEM pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
CGEM Dividend Yield
Cullinan Therapeutics, Inc. (CGEM) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CGEM pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Cullinan Therapeutics, Inc. (CGEM) — Dividend Analysis 2026
Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. It engages in the development of CLN-978, a CD19xCD3 bispecific T cell engager for autoimmune diseases in Phase 1 clinical trials; Velinotamig, a BCMAxCD3 bispecific T cell in Phase 1 clinical trials in patients with autoimmune diseases; and CLN-049, a FLT3xCD3 bispecific T cell engager, which is in Phase 1 clinical trials in patients with relapsed and refractory acute myeloid leukemia or myelodysplastic syndrome. The company is also developing Zipalertinib, an orally available small-molecule, irreversible epidermal growth factor receptor inhibitor in Phase 2b portion of the REZILIENT1 clinical trial in patients with EGFR ex20ins non-small cell lung cancer. It has a license agreement with Chongqing Genrix Biopharmaceutical Co., Ltd to develop and commercialize velinotamig; a co-development agreement with Taiho Pharmaceutical Co., Ltd to develop zipalertinib; and a collaboration agreement with Adimab, LLC to discover and/or optimize antibodies. The company was formerly known as Cullinan Oncology, Inc. and changed its name to Cullinan Therapeutics, Inc. in April 2024. Cullinan Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
CGEM Dividend & DRIP — Frequently Asked Questions
Does CGEM pay a dividend?
No. Cullinan Therapeutics, Inc. (CGEM) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of CGEM?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does CGEM have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. CGEM has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to CGEM
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CGEM DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CGEM position with:
🌍 CGEM Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CGEM.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CGEM Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CGEM Dividend Payment Schedule
CGEM pays quarterly — 4 times per year. Ex-div: —.
📊 CGEM vs Healthcare Benchmarks
How CGEM compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CGEM sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CGEM Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-09-08 | 4,000 | $4.30 | $17.2K | ||
| Sale | 2026-09-08 | 8,000 | $21.57 | $172.6K | ||
| M-Exempt | 2026-09-08 | 4,000 | $4.30 | $17.2K | ||
| M-Exempt | 2026-08-13 | 30,000 | $4.30 | $129.0K | ||
| Sale | 2026-08-13 | 30,000 | $20.26 | $607.8K | ||
| M-Exempt | 2026-08-13 | 30,000 | $4.30 | $129.0K | ||
| M-Exempt | 2026-07-06 | 4,000 | $4.30 | $17.2K | ||
| Sale | 2026-07-06 | 8,000 | $17.82 | $142.6K | ||
| M-Exempt | 2026-07-06 | 4,000 | $4.30 | $17.2K | ||
| A-Award | 2026-06-30 | 2,470 | $8.60 | $21.2K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare CGEM with peers: CGEM vs ADCT · CGEM vs BCYC · CGEM vs CBLL
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CGEM dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Cullinan Therapeutics, Inc. (CGEM) is currently trading at $14.37, 38% below its 52-week high. It does not currently pay a regular dividend.
Does CGEM Pay a Dividend? Cullinan Therapeutics, Inc. Dividend Status
Cullinan Therapeutics, Inc. (CGEM) is a healthcare stock trading at $14.37. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest CGEM News
LiveProjected your CGEM DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.